Lesson plan

R1317

R1317 is a desmethylprodine analog in which the N-methyl group is replaced by a cinnamyl group. This change in sidechain endows the compound with an increase in potency. The compound is 261 times more potent than meperidine in mice and 1100 times more potent in rats. In another article it was stated to be 785 times more potent than meperidine. Despite this high potency, it is not the most potent 4-phenylpiperidine-reverse ester ever created. The most potent 4-phenylpiperidine-reverse ester ever created is R1480. R1480 is stated to have a potency 1500-3180 times higher than meperidine in mice and 3040 times higher in rats. It was investigated as a candidate for a non-lethal incapacitating agent, but was discarded due to its high toxicity in primates. The substituted 2-nitrocinnamyl, EA 2475, is 282 times more potent (analgesic potency = 28000) and have a therapeutic index superior to remifentanil, in mices, but it is highly toxic and ineffective for primates. None of these compounds were adopted as incapacitating agents, with the likely agent adopted being the EA 3382.

Back to article

Article summary

R1317 is a desmethylprodine analog in which the N-methyl group is replaced by a cinnamyl group. This change in sidechain endows the compound with an increase in potency. The compound is 261 times more potent than meperidine in mice and 1100 times more potent in rats. In another article it was stated to be 785 times more potent than meperidine. Despite this high potency, it is not the most potent 4-phenylpiperidine-reverse ester ever created. The most potent 4-phenylpiperidine-reverse ester ever created is R1480. R1480 is stated to have a potency 1500-3180 times higher than meperidine in mice and 3040 times higher in rats. It was investigated as a candidate for a non-lethal incapacitating agent, but was discarded due to its high toxicity in primates. The substituted 2-nitrocinnamyl, EA 2475, is 282 times more potent (analgesic potency = 28000) and have a therapeutic index superior to remifentanil, in mices, but it is highly toxic and ineffective for primates. None of these compounds were adopted as incapacitating agents, with the likely agent adopted being the EA 3382.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.